According to a recent study, 68% of EU and US pharma executives say their business model is broken. Shrinking margins, patent losses and decreasing access to healthcare stakeholders challenge existing processes, organizational structures and roles. Meanwhile, governments everywhere are seeking ways to control healthcare costs and are looking for value based reimbursement models to cap the drug prices their public health systems are willing to pay. There is now an urgent need to take a broader view on what innovation can mean - including new services, new partnerships and above all innovative business models.
Instead of just selling pills, life science companies need to find more patient-centric ways of identifying, delivering and capturing value. This conference will exclusively bring together innovation leaders from inside and outside the healthcare sector to share the best ideas on future markets.
Reasons to attend:
- Discover how to successfully access new markets in healthcare
- Improve business outcomes and prove value for money
- Understand how megatrends like patient empowerment and digital healthcare shake up the traditional role of all stakeholders involved
- Involve patient and payor requirements in new business models
- Drive value in healthcare though data analytics and information technology
- Hear what future collaborations with partners from inside and outside the health sector could look like
Get on board to share and discuss your ideas. Register now and benefit from a € 250 early registration discount.
For further information and registration, please visit:
http://www.pharma-summit.com